Impact of San-mediated Signaling on Glioblastoma and Neuroblastoma Metabolism
Glioblastoma (GBM) is the most common and aggressive type of brain cancer, with an average life expectancy of 15 months. The standard of care for GBM, surgery accompanied by radiation and chemotherapy (temozolomide-TMZ), has not changed in over 10 years illustrating the need for new and efficacious...
| Main Author: | |
|---|---|
| Format: | Others |
| Published: |
FIU Digital Commons
2018
|
| Subjects: | |
| Online Access: | https://digitalcommons.fiu.edu/etd/3751 https://digitalcommons.fiu.edu/cgi/viewcontent.cgi?article=5058&context=etd |